TABLE 3.
Mutations in HRV-2 variants selected by passaging in the presence of AZ5385
| Protein | Alterationa in | |||||
|---|---|---|---|---|---|---|
| Control virus passage 11 | AZ5385 virus passage 11 | |||||
| V1b | V2 | V3 | V1 | V2 | V3 | |
| VP1 | t2852a S181T |
t2852a S181T |
t2852a S181T |
|||
| VP1 | a2939g T210A |
a2939gc T210A |
a2939g T210A |
|||
| Polymerase | t6610c silent | t6610c silent | t6610c silent | |||
Mutations found in HRV-2 passaged in the absence (control virus passage) or the presence of inhibitor as related to original HRV-2. Nucleotide substitutions are denoted with lowercase letters and followed by predicted amino acid changes. Numbering of nucleotide is based on the GenBank HRV-A2 strain X02316. Numbering of amino acid residues is based on published cleavage sites of HRV-2 polyprotein (UniProt, P04936).
Viral variants (V1–V3) purified by limiting dilution method.
Substitution accompanied by a background of original base.